While CEO Kirk Tanner didn't specify the connection, GLP-1 drug users have documented an unofficial side effect commonly ...

Kirk Tanner sees opportunities for the chocolate maker, as it navigates weight-loss drugs and stretched consumers.

Hershey reports gum and mint sales boost linked to "Ozempic breath" ...

Hershey CEO Kirk Tanner says the company has seen an increase in demand for certain products.

Sales of Hershey's Ice Breakers rose 8% in the first quarter, thanks to the trend.

Hershey says it's benefiting from the growing use of GLP-1 weight-loss drugs even as people cut down on snacks. Here's why.

Q1 2026 Management View CEO Kirk Tanner framed the competitive backdrop as stable on pricing while acknowledging earlier-than-expected activity in the aisle, saying, "competition continues to be ...

Hershey attributes a sharp increase in sales of its Ice Breakers breath mints to reports linking GLP-1 weight-loss drugs to ...

Hershey's gum and mint sales are rising as GLP-1 weight-loss drug users seek relief from side effects like 'Ozempic breath'.

Eau, eau, eau, Eau-zempic! You’ve heard of “Ozempic butt,” “Ozempic fingers,” “Ozempic mouth” and “Ozempic teeth” — now, ...

Hershey beat first-quarter earnings estimates, with CEO Kirk Tanner citing strong gum and mint sales driven partly by GLP-1 weight-loss drug users seeking to counter 'Ozempic breath.' Ice Breakers ...